This is a special edition episode - Ed Tate, Director of Communications at the Hepatitis B Foundation was able to sit down with Dr. Stephan Urban the developer of the hepatitis D drug, Hepcludex. The drug, which blocks the entry of the hepatitis B and hepatitis D virus into the liver cell, was approved by the European Commission on 31 July 2020.  Listen for more of their conversation. Consider donating here to support programs like B Heppy!  Questions? Send them to: [email protected] Support the show (https://interland3.donorperfect.net/weblink/weblink.aspx?name=hepb&id=165)